Annual Shareholders Equity
$10.67 M
-$17.64 M-62.30%
December 31, 2023
Summary
- As of February 10, 2025, ONTX annual stockholders equity is $10.67 million, with the most recent change of -$17.64 million (-62.30%) on December 31, 2023.
- During the last 3 years, ONTX annual shareholders equity has risen by +$4.50 million (+72.83%).
Performance
ONTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$6.01 M
-$4.66 M-43.64%
March 31, 2024
Summary
- As of February 10, 2025, ONTX quarterly stockholders equity is $6.01 million, with the most recent change of -$4.66 million (-43.64%) on March 31, 2024.
- Over the past year, ONTX quarterly shareholders equity has dropped by -$4.66 million (-43.64%).
Performance
ONTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ONTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.3% | -43.6% |
| 3 y3 years | +72.8% | -43.6% |
| 5 y5 years | +98.1% | -43.6% |
ONTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.9% | at low | -87.0% | at low |
| 5 y | 5-year | -76.9% | -42.1% | -87.9% | at low |
| alltime | all time | -86.7% | -1583.4% | -93.6% | -2975.2% |
Onconova Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $6.01 M(-43.6%) |
| Dec 2023 | $10.67 M(-62.3%) | $10.67 M(-26.5%) |
| Sep 2023 | - | $14.52 M(-23.2%) |
| Jun 2023 | - | $18.90 M(-17.4%) |
| Mar 2023 | - | $22.88 M(-19.2%) |
| Dec 2022 | $28.31 M(-38.6%) | $28.31 M(-15.2%) |
| Sep 2022 | - | $33.37 M(-13.3%) |
| Jun 2022 | - | $38.48 M(-9.0%) |
| Mar 2022 | - | $42.29 M(-8.3%) |
| Dec 2021 | $46.12 M(+646.9%) | $46.12 M(-7.1%) |
| Sep 2021 | - | $49.67 M(+50.5%) |
| Jun 2021 | - | $32.99 M(-11.2%) |
| Mar 2021 | - | $37.15 M(+501.7%) |
| Dec 2020 | $6.17 M(-46.6%) | $6.17 M(-49.4%) |
| Sep 2020 | - | $12.21 M(-21.9%) |
| Jun 2020 | - | $15.63 M(-26.8%) |
| Mar 2020 | - | $21.35 M(+84.4%) |
| Dec 2019 | $11.57 M(+114.9%) | $11.57 M(-291.6%) |
| Sep 2019 | - | -$6.04 M(+32.9%) |
| Jun 2019 | - | -$4.55 M(+196.0%) |
| Mar 2019 | - | -$1.54 M(-128.5%) |
| Dec 2018 | $5.39 M | $5.39 M(-50.4%) |
| Sep 2018 | - | $10.86 M(-31.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $15.91 M(-306.6%) |
| Mar 2018 | - | -$7.71 M(-34.1%) |
| Dec 2017 | -$11.69 M(-372.1%) | -$11.69 M(+69.2%) |
| Sep 2017 | - | -$6.91 M(+1680.4%) |
| Jun 2017 | - | -$388.00 K(-89.0%) |
| Mar 2017 | - | -$3.54 M(-182.4%) |
| Dec 2016 | $4.30 M(-57.1%) | $4.30 M(-53.2%) |
| Sep 2016 | - | $9.19 M(+654.7%) |
| Jun 2016 | - | $1.22 M(-79.7%) |
| Mar 2016 | - | $5.99 M(-40.2%) |
| Dec 2015 | $10.01 M(-56.0%) | $10.01 M(+197.2%) |
| Sep 2015 | - | $3.37 M(-10.1%) |
| Jun 2015 | - | $3.75 M(-68.1%) |
| Mar 2015 | - | $11.76 M(-48.3%) |
| Dec 2014 | $22.75 M(-71.7%) | $22.75 M(-35.5%) |
| Sep 2014 | - | $35.27 M(-27.3%) |
| Jun 2014 | - | $48.52 M(-24.1%) |
| Mar 2014 | - | $63.91 M(-20.5%) |
| Dec 2013 | $80.41 M(-150.8%) | $80.41 M(-14.3%) |
| Sep 2013 | - | $93.83 M(-154.3%) |
| Jun 2013 | - | -$172.94 M(-712.9%) |
| Mar 2013 | - | $28.21 M(-117.8%) |
| Dec 2012 | -$158.31 M(+14.4%) | -$158.31 M |
| Dec 2011 | -$138.42 M | - |
FAQ
- What is Onconova Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Onconova Therapeutics?
- What is Onconova Therapeutics annual shareholders equity year-on-year change?
- What is Onconova Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Onconova Therapeutics?
- What is Onconova Therapeutics quarterly shareholders equity year-on-year change?
What is Onconova Therapeutics annual stockholders equity?
The current annual shareholders equity of ONTX is $10.67 M
What is the all time high annual shareholders equity for Onconova Therapeutics?
Onconova Therapeutics all-time high annual stockholders equity is $80.41 M
What is Onconova Therapeutics annual shareholders equity year-on-year change?
Over the past year, ONTX annual stockholders equity has changed by -$17.64 M (-62.30%)
What is Onconova Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ONTX is $6.01 M
What is the all time high quarterly shareholders equity for Onconova Therapeutics?
Onconova Therapeutics all-time high quarterly stockholders equity is $93.83 M
What is Onconova Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ONTX quarterly stockholders equity has changed by -$4.66 M (-43.64%)